1-(3-trifluoromethylphenyl)piperazine has been researched along with arginine vasopressin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, Y; Hashimoto, K; Kageyama, J; Murakami, K; Ohno, N; Takahara, J | 1 |
1 other study(ies) available for 1-(3-trifluoromethylphenyl)piperazine and arginine vasopressin
| Article | Year |
|---|---|
The effect of serotonin agonist 1-(trifluoromethylphenyl)-piperazine on corticotropin releasing factor and arginine vasopressin in rat hypothalamic nuclei.
Topics: Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; Corticotropin-Releasing Hormone; Hypothalamus, Middle; Male; Piperazines; Rats; Rats, Inbred Strains | 1982 |